202: Preliminary Results of a Phase I Study of Immuno-Chemotherapy (CTX) Conditioning with Gemtuzumab Ozogamicin (GO), Busulfan (Bu) and Cyclophosphamide (Cy) Followed by Allogeneic Stem Cell Transplantation (AlloSCT) in Pediatric Recipients with High Risk (HR) CD33+ Acute Myelogenous Leukemia (AML)

✍ Scribed by I. Waxman; M. Bhatia; E. Qualter; Z.Z. Jin; V. Kohl; L. Baldinger; J. Guerra; J. Garvin; D. George; M.B. Bradley; P. Satwani; J. Schwartz; L.A. Baxter-Lowe; K. Wolonik; S. Foley; R. Hawks; O. Militano; C. van de Ven; C.S. Mitchell

• Book ID: 116280029
• Publisher: Elsevier Science
• Year: 2008
• Tongue: English
• Weight: 59 KB
• Volume: 14
• Category: Article
• ISSN: 1083-8791
• DOI: 10.1016/j.bbmt.2007.12.211